ASBP

Aspire Biopharma
ASBP

Overview Fund Trends Analyst Outlook Journalist POV

54 hedge funds and large institutions have $241M invested in Aspire Biopharma in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$21M
2
+$20.4M
3
+$19.6M
4
AA
AQR Arbitrage
Connecticut
+$13.4M
5
HCM
Highbridge Capital Management
New York
+$11.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.99M
27
$2.52M
28
$2.5M
29
$2M
30
$2M
31
$2M
32
$2M
33
$1.5M
34
$1.5M
35
$1.22M
36
$998K
37
$985K
38
$749K
39
$499K
40
$499K
41
$499K
42
$487K
43
$432K
44
$373K
45
$295K
46
$295K
47
$278K
48
$250K
49
$215K
50
$166K
1
2
3